The best fashion trends combine style and practicality with a bit of fun. So it’s no surprise that wedge sandals, a nostalgic alternative to heels, are having their very own renaissance this season.

If you have an AMD graphics card, then you need the AMD Catalyst Control Center which is a part of the AMD Catalyst software engine that provides customization options to manage display settings.

Last summer saw flip-flops undergo a full-fledged fashion transformation, reemerging in luxe leather, sculptural silhouettes and heeled iterations that moved seamlessly from the runway to the red ...

With an eye on the lucrative U.S. market, Italy’s Angelini Pharma will acquire rare disease specialist Catalyst Pharmaceuticals and its potential blockbuster, Firdapse, for $4.1 billion. Rome-based ...

Rare-disease specialist Catalyst Pharmaceuticals is set to be acquired by healthcare group Angelini Pharma in a $4.1 billion deal. Angelini will pay $31.50 for each of Nasdaq-listed Catalyst’s ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. The Italian company Angelini Pharma ...

State-backed CDP Equity to have a stake in combined entity Deal comes after Chiesi's $1.9 billion buyout of U.S. KalVista Angelini aims to create global player in rare disease drugs ROME/MILAN, May 7 ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

Italian drugmaker Angelini Pharma is exploring a potential acquisition of Catalyst Pharmaceuticals Inc. as it looks at deals to expand its footprint globally, people familiar with the matter said.

NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Cory Fernandez Commerce Editor If you’re one of the many ...

RESEARCH TRIANGLE PARK, N.C. & NOTTINGHAM, England--(BUSINESS WIRE)--Worldwide Clinical Trials (“Worldwide” or the “Company”), a global contract research organization (CRO), has completed its ...